Eric S Wolf

2026 Los Angeles Miracles for Myeloma 5K Run/Walk fundraise.myeloma.org/event/2026-los… Run with me to cure myeloma, research for better therapies and supporting patients with myeloma with resources Saturday 3/21 @ Griffith park, LA 9 am.... @ctoddkennedy @EricWolf_USMC @DianeKennedyOC

@JanakiramMurali @ctoddkennedy @DianeKennedyOC Go Dr Janakiram and Team!! Thank you for all you do. We love our CoH care team!

@blondie1746 Yes! Amen! 14 years for me and I am #morethanmyeloma

I was 49 when I was diagnosed. And after 14.5 years, I am #morethanmyeloma.

@DoctorAKrishnan Congratulations Todd and Diane! You’re the best. We all love and appreciate you.

American cancer society gala: congratulations to Todd and Diane Kennedy who were honored as volunteers of the year. Thank you for leading the support group at city of hope and for your advocacy for MM research

Follow Myeloma Action Month, #morethanmyeloma, #IMFMyeloma

@DoctorAKrishnan I love this technology. Sign me up.

Celebrating the launch of Jay Seq, the rapid WGS test for myeloma developed by Dr Johnathan Keats and supported by the Nason Hollingsworth families.

The major change was all due to the unprecedented results of Majestec-3 trial #ASH25 I cannot emphasize enough that to do Tec-Dara safely you absolutely need good preventive measures: close monitoring, routine monthly IVIG, and other infection prevention measures as in the trial. 👇👇

Immunotherapy combination of teclistamab and daratumumab heralded as potential 'functional cure' for multiple myeloma | Breaking News from Late Breaking Abstract. #ASH25 IMFASH25 ⁦@IMFmyeloma⁩ managedhealthcareexecutive.com/view/immunothe…

@TerryGlassman @jmikhaelmd This is truly amazing! I loved @IMFnurseMyeloma, Teresa Miceli’s comment, “You could drive a truck through that [the gap between the Tec-Dara and SOC curves].”! Fantastic!

Still in a plane but this exciting news is finally out. Tech/Dara! Look at that curve (or lack thereof) my fellow patients! Way to end on a hopeful note #ASH25 #IMFASH25 #myeloma #mmsm @jmikhaelmd

@IMFjimMYELOMA One of the highlights of ASH with more research to come I hope.

Dual Targeting of GPRC5D and BCMA Gets High Response Rate in Extramedullary Myeloma medpagetoday.com/meetingcoverag…

Join Me LIVE from the 2025 American Society of Hematology (ASH) Meeting #IMFASH25 #IMF25 myeloma.org/videos/join-us…

This figure from my friend Peter Vorhees has to be the most complicated and weirdly beautiful I’ve ever seen

What happens when a patient is refractory to both BCMA and GPRC5D directed CARs and Bi-Specifics? #ASH25 #IMFASH25 ⁦@IMFmyeloma⁩ ⁦@JanakiramMurali⁩ #imwg

Tri-specific under investigation. 100% ORR, 78% >CR, 12-month PFS = 96%! Way to go City of Hope and Dr. Amrita Krishnan. #IMFASH25 #ASH25 ⁦@DoctorAKrishnan⁩ ⁦@JanakiramMurali⁩ ⁦@IMFmyeloma⁩

Are you High Risk? Does your myeloma show any of these signs? #IMFASH25 #ASH25 ⁦@IMFmyeloma⁩

This is one of the best slides I’ve seen at ASH! In study after study, we’re seeing high rates of MRD! #IMFASH25 #ASH25 ⁦@IMFmyeloma⁩

What motivates you? The Voices of ASH 2025, bring the patient perspective to the American Society of Hematology. #ASH25 #IMFASH25 ⁦@IMFmyeloma⁩

The Rock Stars of Myeloma! 300 Docs of the International Myeloma Working Group. Just sat as a fly on the wall in their meeting. I’m so grateful and humbled by all they do for us patients.